Hirsh J - Search Results

1

Effects on thrombin generation of single injections of Hirulog in patients with calf vein thrombosis.

Ginsberg JS, Nurmohamed MT, Gent M, MacKinnon B, Stevens P, Weitz J, Maraganore J, Hirsh J. Ginsberg JS, et al. Among authors: hirsh j. Thromb Haemost. 1994 Oct;72(4):523-5. Thromb Haemost. 1994. PMID: 7878625 Clinical Trial.

2

The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement.

Levine MN, Planes A, Hirsh J, Goodyear M, Vochelle N, Gent M. Levine MN, et al. Among authors: hirsh j. Thromb Haemost. 1989 Nov 24;62(3):940-4. Thromb Haemost. 1989. PMID: 2556813

3

Advances in antithrombotic therapy: novel agents.

Turpie AG, Weitz JI, Hirsh J. Turpie AG, et al. Among authors: hirsh j. Thromb Haemost. 1995 Jul;74(1):565-71. Thromb Haemost. 1995. PMID: 8578525 Review.

4

Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.

Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, Geerts W, LeClerc J, Neemeh J, Powers P, et al. Levine MN, et al. Among authors: hirsh j. Thromb Haemost. 1995 Aug;74(2):606-11. Thromb Haemost. 1995. PMID: 8584992 Clinical Trial.

5

The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.

Anand S, Ginsberg JS, Kearon C, Gent M, Hirsh J. Anand S, et al. Among authors: hirsh j. Arch Intern Med. 1996 Aug 12-26;156(15):1677-81. Arch Intern Med. 1996. PMID: 8694666

6

The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study.

Rajan R, Levine M, Gent M, Hirsh J, Geerts W, Skingley P, Julian J. Rajan R, et al. Among authors: hirsh j. Thromb Haemost. 1998 Jan;79(1):19-22. Thromb Haemost. 1998. PMID: 9459315 Clinical Trial.

7

Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.

Crowther MA, Roberts J, Roberts R, Johnston M, Stevens P, Skingley P, Patrassi GM, Sartori MT, Hirsh J, Prandoni P, Weitz JI, Gent M, Ginsberg JS. Crowther MA, et al. Among authors: hirsh j. Thromb Haemost. 2001 Mar;85(3):390-4. Thromb Haemost. 2001. PMID: 11307802 Clinical Trial.

8

Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial.

Paikin JS, Hirsh J, Ginsberg JS, Weitz JI, Chan NC, Whitlock RP, Pare G, Johnston M, Eikelboom JW. Paikin JS, et al. Among authors: hirsh j. J Thromb Haemost. 2015 Mar;13(3):448-56. doi: 10.1111/jth.12832. Epub 2015 Feb 6. J Thromb Haemost. 2015. PMID: 25546465 Free article. Clinical Trial.

9

The effect of thrombin inhibitors on tissue plasminogen activator induced thrombolysis in a rat model.

Klement P, Borm A, Hirsh J, Maraganore J, Wilson G, Weitz J. Klement P, et al. Among authors: hirsh j. Thromb Haemost. 1992 Jul 6;68(1):64-8. Thromb Haemost. 1992. PMID: 1514174

10

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M; Fixed-Dose Heparin (FIDO) Investigators. Kearon C, et al. Among authors: hirsh j. JAMA. 2006 Aug 23;296(8):935-42. doi: 10.1001/jama.296.8.935. JAMA. 2006. PMID: 16926353 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

929 results

Search Page

Filters